Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Prevalence of anti-drug antibodies against interferon beta has decreased since routine analysis of neutralizing antibodies became clinical practice.
Pregnancy level of estrogen attenuates experimental autoimmune encephalomyelitis in both ovariectomized and pregnant C57BL/6 mice through expansion of Treg and Th2 cells.
Vitamin D receptor binding, chromatin states and association with multiple sclerosis.
Altered microRNA expression in B lymphocytes in multiple sclerosis: Towards a better understanding of treatment effects.
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.
Cyclophosphamide
The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis. The Canadian Cooperative Multiple Sclerosis Study Group.
22nd Meeting of European Neurological Society
Predictors of quality of life among multiple sclerosis patients: a comprehensive analysis.
Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain.
Artielle Immunotherapeutics Announces Positive Results of Phase ! Multiple Sclerosis Trial
Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis.
Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy.
Circulating microRNAs as biomarkers for disease staging in multiple sclerosis.
English Court of Appeal finds in favor of Teva on Copaxone(R) patent litigation and upholds validity of Copaxone patent until May 2015
Motor skill learning requires active central myelination.
First reported case of diabetes mellitus type 1 as a possible secondary autoimmune disease following alemtuzumab treatment in MS.
Synthesis and biological evaluation of new 1,2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for treatment of autoimmune disorders: structure-activity relationship.
Epidemiology of multiple sclerosis in Australia. With NSW and SA survey results.
Anejaculatory infertility due to multiple sclerosis.
Therapeutic Testosterone Administration Preserves Excitatory Synaptic Transmission in the Hippocampus during Autoimmune Demyelinating Disease.
Severe anemia in a patient with multiple sclerosis treated with natalizumab.
Multiple sclerosis and progressive resistance training: a systematic review.
Acorda Therapeutics announces top line results of post-marketing commitment study exploring 5 mg dose of dalfampridine-ER
Adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational SMART study.

Pages